Frankfurt - Delayed Quote EUR
Enlivex Therapeutics Ltd. (1BT.F)
0.7950
+0.0150
+(1.92%)
As of 8:02:51 AM GMT+2. Market Open.
Research Analysis
Earnings Estimate
Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
---|---|---|---|---|
No. of Analysts | -- | -- | -- | -- |
Avg. Estimate | 0 | 0 | 0 | 0 |
Low Estimate | 0 | 0 | 0 | 0 |
High Estimate | 0 | 0 | 0 | 0 |
Year Ago EPS | -- | -- | -- | -- |
Revenue Estimate
Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
---|---|---|---|---|
No. of Analysts | 1 | 1 | 2 | 1 |
Avg. Estimate | -- | -- | -- | -- |
Low Estimate | -- | -- | -- | -- |
High Estimate | -- | -- | -- | -- |
Year Ago Sales | -- | -- | -- | -- |
Sales Growth (year/est) | 0.00% | 0.00% | 0.00% | 0.00% |
EPS Trend
Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
---|---|---|---|---|
Current Estimate | 0 | 0 | 0 | 0 |
7 Days Ago | 0 | 0 | 0 | 0 |
30 Days Ago | 0 | 0 | 0 | 0 |
60 Days Ago | 0 | 0 | 0 | 0 |
90 Days Ago | 0 | 0 | 0 | 0 |
EPS Revisions
Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
---|---|---|---|---|
Up Last 7 Days | -- | -- | -- | -- |
Up Last 30 Days | -- | -- | -- | -- |
Down Last 7 Days | -- | -- | -- | -- |
Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
Current Qtr. | Next Qtr. | Current Year | Next Year | |
---|---|---|---|---|
1BT.F | -- | -- | -- | -- |
S&P 500 | 6.94% | 4.52% | 8.32% | 14.18% |
Upgrades & Downgrades
Maintains | D. Boral Capital: Buy to Buy | 4/21/2025 |
Maintains | D. Boral Capital: Buy to Buy | 4/3/2025 |
Maintains | HC Wainwright & Co.: Buy to Buy | 3/24/2025 |
Maintains | D. Boral Capital: Buy to Buy | 3/3/2025 |
Maintains | D. Boral Capital: Buy to Buy | 2/7/2025 |
Maintains | D. Boral Capital: Buy to Buy | 12/11/2024 |
Related Tickers
PYPD PolyPid Ltd.
2.6700
-2.91%
BCDA BioCardia, Inc.
1.8400
-1.08%
CELU Celularity Inc.
1.6850
+4.66%
ALZN Alzamend Neuro, Inc.
0.6700
-2.20%
CVKD Cadrenal Therapeutics, Inc.
16.92
+0.24%
BCLI Brainstorm Cell Therapeutics Inc.
0.8800
+1.25%
LGVN Longeveron Inc.
1.6430
+2.04%
BSEM BioStem Technologies, Inc.
13.91
+18.89%
LXEO Lexeo Therapeutics, Inc.
3.4650
+2.82%
VIR Vir Biotechnology, Inc.
6.14
+2.85%